Diploma (LON:DPLM) Receives Buy Rating from Shore Capital

Shore Capital reiterated their buy rating on shares of Diploma (LON:DPLM) in a research note published on Monday morning, MarketBeat.com reports.

Diploma Price Performance

LON DPLM opened at GBX 3,308 ($41.39) on Monday. The company’s 50 day simple moving average is GBX 2,967.34 and its 200 day simple moving average is GBX 3,025.20. The firm has a market capitalization of £4.43 billion, a PE ratio of 3,572.34, a P/E/G ratio of 2.82 and a beta of 0.68. Diploma has a 12 month low of GBX 2,524.50 ($31.58) and a 12 month high of GBX 3,386 ($42.36). The company has a debt-to-equity ratio of 33.34, a current ratio of 1.87 and a quick ratio of 0.80.

Diploma Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, February 2nd. Investors of record on Thursday, January 18th will be paid a GBX 40 ($0.50) dividend. This represents a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, January 18th. This is a positive change from Diploma’s previous dividend of $16.50. Diploma’s payout ratio is presently 5,851.06%.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, instrumentation and consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.